Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Echocardiography Aids Fetus with Heart Defect

By HospiMedica staff writers
Posted on 05 Jul 2001
A study has shown that newborns with hypoplastic left heart syndrome (HLHS) are less likely to experience early neurologic problems, such as seizure or coma, if HLHS is diagnosed before birth by fetal echocardiography. More...
Conducted by researchers at The Children's Hospital of Philadelphia (PA, USA), the study was published in the June 2001 issue of Pediatrics.

Fetal echocardiography is increasingly used to detect congenital heart defects before birth, although whether prenatal diagnosis benefits children with heart disease has been questioned. The new study showed that the prenatal detection allowed better treatment, such as delivering the baby at a hospital with an advanced high-risk nursery and promptly administering the drug prostaglandin to maintain blood flow until the first stage of reconstructive surgery can be performed. Compared to newborns with HLHS diagnosed after birth, infants diagnosed prenatally were half as likely to experience seizure or coma prior to or within six weeks of their surgery.

The researchers studied 216 newborns with HLHS, 79 of whom were diagnosed prenatally. They found survival rates after the first stage of surgery to be the same, 74%, regardless of whether HLHS was diagnosed before or after birth. Since the period of that study, survival rates have continued to improve. At Children's Hospital, 86% of infants with HLHS survived the first stage of surgery from January 1999-April 2000. However, children with HLHS remain at a higher risk of long-term cognitive and neurologic problems compared to children with other heart defects.

"We hope to show that prenatal diagnosis, in addition to reducing short-term neurologic problems, also improves long-term functioning,” said William T. Mahle, M.D., a cardiologist at the hospital and lead author of the study. "We will follow the children in the study as they attain school age to assess how well they're doing cognitively and neurologically.”




Related Links:
Children's Hospital of Philadelphia

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.